A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2002
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6472178 Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
10/29/2002	US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/29/2002	US6471969 Two-phase preparation
10/29/2002	CA2094481C Processes for the preparation of amylase inhibitor
10/25/2002	WO2001083451A1 Novel bicyclic compounds
10/25/2002	WO2001078652A2 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/25/2002	CA2443806A1 Methods for drug discovery, disease treatment, and diagnosis using metabolomics
10/25/2002	CA2383175A1 Methods and kits for treating depression or preventing deterioration of cognitive function
10/24/2002	WO2002084298A2 Medicaments which are modulators of hm74 and/or hm74a activity
10/24/2002	WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	WO2002083950A1 Methods and compositions for treating cardiovascular disease using 10218
10/24/2002	WO2002083936A2 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083841A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083734A2 Modified calcitonin
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083684A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002	WO2002083658A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083632A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083616A1 α-SUBSTITUTED φ-ARYLFATTY ACID DERIVATIVE
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083159A1 Palliative effects of morinda citrifolia oil and juice
10/24/2002	WO2002083147A1 Use of bile acid or bile salt fatty acid conjugates
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083134A1 Aryl and biaryl piperidines used as mch antagonists
10/24/2002	WO2002083128A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	WO2002083127A1 Protein modification-inhibitory compositions
10/24/2002	WO2002083120A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	WO2002083115A1 Treatment of disorders secondary to organic impairments
10/24/2002	WO2002083109A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002	WO2002083106A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002	WO2002083083A2 Pharmaceutically active compounds and methods of use
10/24/2002	WO2002083066A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002	WO2002083058A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002	WO2002082930A1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same
10/24/2002	WO2002082929A1 Improved edible compositions for lowering cholesterol
10/24/2002	WO2002066035A3 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/24/2002	WO2002055522A3 Novel multi-ring organic compounds for regulating gut motility and food intake
10/24/2002	WO2002053140A3 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002	WO2002024659A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists
10/24/2002	WO2002003972A3 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
10/24/2002	WO2001081327A1 Novel stable crystal of thiazolidinedione derivative and process for producing the same
10/24/2002	WO2001076568B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/24/2002	WO2001047529A3 Association of deoxyfructosazine and an antidiabetic agonist of the peroxysome proliferator gamma-activated receptor
10/24/2002	WO2000040247A9 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/24/2002	US20020157126 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass
10/24/2002	US20020156292 Anticancer agents
10/24/2002	US20020156275 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156254 Nucleotide sequences coding polypeptide for use in the treatment of stress, diabetes, cancer, inflammatory and cardiovascular disorders
10/24/2002	US20020156243 Adipocyte-specific protein homologs
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156116 Antiproliferative agents for disorders with GRB-2 adaptor protein function; treating diabetes, insulin resistance, insulin deficiency and insulin allergy
10/24/2002	US20020156111 Substituted bicyclic compounds
10/24/2002	US20020156104 Novel pyrazole and pyrazoline substituted compounds
10/24/2002	US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156067 New drug combinations
10/24/2002	US20020156051 Atherosclerosis and hyperlipidemia; ascorbic acid and anticholesterol agents that are 3-hydroxy-3-methyl glutaryl coenzyme-A reductase inhibitors
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier
10/24/2002	US20020156030 Heterocyclic aromatic compounds and uses thereof
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002	US20020155534 SBHWSB2: a new member of the WD40 SOCS box family
10/24/2002	US20020155144 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/24/2002	US20020155115 Cancer therapy
10/24/2002	US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002	US20020155091 For reducing serum cholesterol in a mammal
10/24/2002	US20020155067 For drug delivery
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	CA2770489A1 Bisphosphonate conjugates and methods of making and using the same
10/24/2002	CA2763637A1 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
10/24/2002	CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002	CA2447008A1 Controlled delivery of tetracycline compounds and tetracycline derivatives
10/24/2002	CA2445029A1 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444253A1 Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof

1 ... 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 ... 1298